The National Institutes of Health issued last week a request for applications for research projects focused on the development of therapeutics, including those based on siRNA, for biodefense applications.

The NIH also recently reissued requests for applications for two other funding opportunities, one focused on the use of mouse models to study joint degeneration and one exploring the relationship between Fragile X syndrome and autism — and both with RNAi components.

Biodefense